Key result
Leadless pacemaker implantation via the RIJV achieves an ~85% success rate without major access complications.
Why the study?
Leadless pacemaker implantation via the right internal jugular vein may overcome limitations of the femoral approach, but evidence in centers without cardiac surgery is limited.
Does leadless pacemaker implantation via the right internal jugular vein result in successful and safe implantation in patients treated at a center without cardiac surgery?
Observational (n=34)
No
Does leadless pacemaker implantation via the right internal jugular vein result in successful and safe implantation in patients treated at a center without cardiac surgery?
The right internal jugular vein approach is a feasible and safe alternative to femoral access for leadless pacemaker implantation in centers lacking on-site cardiac surgical backup.
Supports jugular access as alternative in non-surgical centers; leaves open randomized trials versus femoral approach.
BACKGROUND: Leadless pacemaker (LP) implantation via the right internal jugular vein (RIJV) may overcome limitations of the femoral approach, reducing vascular complications, and improving navigation across the tricuspid valve. This study aimed to explore the feasibility and safety of RIJV LP implantation in a center without cardiac surgery. METHODS: observational study of all patients undergoing RIJV LP implantation at an institution without cardiac surgery. RESULTS: Between April 2024 and June 2025, leadless pacemaker implantation via the RIJV was attempted in 34 patients, with a success rate of 85.3 % (n = 29). Implantation failed in five patients due to venous occlusion/stenosis (n = 4) or cardiac tamponade (n = 1). Among successful cases, fluoroscopy and procedure times averaged 7.3 ± 4.9 and 34.9 ± 13.7 minutes, respectively. Most implants (75.8 %) required a single deployment and were placed in the mid-septal area. No major access-related complications occurred. A learning curve was evident, with significant reduction in procedure time across tertiles. No significant differences were found in deployment attempts or final device position among tertiles. CONCLUSIONS: The right jugular approach is feasible and safe, potentially expanding LP implantation among centers without cardiac surgery, though vascular assessment is crucial for patient selection.
No takes yet. Share an insight, caveat, or question.
Figuero et al. (2025) conducted an observational in Bradycardia requiring pacing (Leadless pacemaker indication) (n=34). Right internal jugular vein approach for leadless pacemaker implantation was evaluated on Successful leadless pacemaker implantation (correct device deployment with low pacing threshold and no major periprocedural complications). Leadless pacemaker implantation via the right internal jugular vein was feasible and safe in a center without cardiac surgery, achieving an 85.3% success rate with no major access-related complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: